Rimda Wanchoo

20.6k total citations · 1 hit paper
51 papers, 12.7k citations indexed

About

Rimda Wanchoo is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Oncology. According to data from OpenAlex, Rimda Wanchoo has authored 51 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Nephrology and 14 papers in Oncology. Recurrent topics in Rimda Wanchoo's work include Renal cell carcinoma treatment (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal Diseases and Glomerulopathies (8 papers). Rimda Wanchoo is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal Diseases and Glomerulopathies (8 papers). Rimda Wanchoo collaborates with scholars based in United States, France and Canada. Rimda Wanchoo's co-authors include Kenar D. Jhaveri, Nupur N. Uppal, Vincent Launay‐Vacher, Craig Devoe, Valerie S. Barta, Gilbert Deray, Vanesa Bijol, Purva Sharma, Yuriy Khanin and Hitesh H. Shah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Rimda Wanchoo

48 papers receiving 12.6k citations

Hit Papers

Adverse Renal Effects of Immune Checkpoint Inhibitors: A ... 2017 2026 2020 2023 2017 2.5k 5.0k 7.5k 10.0k

Peers

Rimda Wanchoo
Nupur N. Uppal United States
Craig Devoe United States
Valerie S. Barta United States
Laura Q.M. Chow United States
Michael A. Postow United States
Scott Gettinger United States
Axel Hoos United States
Joseph P. Eder United States
Steven O’Day United States
Nupur N. Uppal United States
Rimda Wanchoo
Citations per year, relative to Rimda Wanchoo Rimda Wanchoo (= 1×) peers Nupur N. Uppal

Countries citing papers authored by Rimda Wanchoo

Since Specialization
Citations

This map shows the geographic impact of Rimda Wanchoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rimda Wanchoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rimda Wanchoo more than expected).

Fields of papers citing papers by Rimda Wanchoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rimda Wanchoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rimda Wanchoo. The network helps show where Rimda Wanchoo may publish in the future.

Co-authorship network of co-authors of Rimda Wanchoo

This figure shows the co-authorship network connecting the top 25 collaborators of Rimda Wanchoo. A scholar is included among the top collaborators of Rimda Wanchoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rimda Wanchoo. Rimda Wanchoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Begum, Farhana, et al.. (2024). Semaglutide-associated kidney injury. Clinical Kidney Journal. 17(9). sfae250–sfae250. 7 indexed citations
2.
Yang, Yihe, Serena M. Bagnasco, Rimda Wanchoo, et al.. (2024). Diffuse Podocytopathy Associated With Semaglutide. SHILAP Revista de lepidopterología. 3(5). 3 indexed citations
3.
Herrmann, Sandra M., Ala Abudayyeh, Shruti Gupta, et al.. (2024). Diagnosis and management of immune checkpoint inhibitor–associated nephrotoxicity: a position statement from the American Society of Onco-nephrology. Kidney International. 107(1). 21–32. 12 indexed citations
4.
Wanchoo, Rimda, et al.. (2024). Paraneoplastic Glomerular Diseases. PubMed. 31(4). 346–357. 2 indexed citations
5.
Wanchoo, Rimda, et al.. (2023). Nirogacestat and Hypophosphatemia. Kidney International Reports. 8(7). 1478–1478. 3 indexed citations
6.
Jhaveri, Kenar D., Vanesa Bijol, Rimda Wanchoo, et al.. (2021). COVID-19 mRNA Vaccine-Associated Autoimmunity Presenting as Minimal Change Disease and Membranous Nephropathy. Journal of the American Society of Nephrology. 32(10S). 94–94. 1 indexed citations
7.
Henderson, David K., Kenar D. Jhaveri, Rimda Wanchoo, & Chintan V. Shah. (2021). Immune Checkpoint Inhibitors Associated Distal RTA with and Without AKI. Journal of the American Society of Nephrology. 32(10S). 576–576.
8.
Bijol, Vanesa, et al.. (2021). The Case | Proteinuria in a patient with hematopoietic stem cell transplantation. Kidney International. 99(5). 1249–1250. 2 indexed citations
9.
Chang, Bessy Suyin Flores, Rushang Parikh, Rimda Wanchoo, Vanesa Bijol, & Kenar D. Jhaveri. (2020). Thrombotic Microangiopathy (TMA) in a Patient with COVID-19. Journal of the American Society of Nephrology. 31(10S). 285–285.
10.
Kitchlu, Abhijat, Kenar D. Jhaveri, Shikha Wadhwani, et al.. (2020). A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease. Kidney International Reports. 6(1). 66–77. 89 indexed citations
11.
Sharma, Purva, Nupur N. Uppal, Rimda Wanchoo, et al.. (2020). COVID-19–Associated Kidney Injury: A Case Series of Kidney Biopsy Findings. Journal of the American Society of Nephrology. 31(9). 1948–1958. 246 indexed citations
12.
Strohbehn, Ian A., Zain Mithani, Jamie S. Hirsch, et al.. (2020). Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2 or on Renal Replacement Therapy. Kidney International Reports. 6(3). 835–838. 19 indexed citations
13.
Mallappallil, Mary C., et al.. (2018). Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologists. BMC Nephrology. 19(1). 147–147. 4 indexed citations
14.
Wanchoo, Rimda, et al.. (2018). Emerging Concepts in Hematopoietic Stem Cell Transplantation–Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments. American Journal of Kidney Diseases. 72(6). 857–865. 28 indexed citations
15.
Jhaveri, Kenar D., Athanasios Saratzis, Rimda Wanchoo, & Pantelis Sarafidis. (2017). Endovascular aneurysm repair (EVAR)– and transcatheter aortic valve replacement (TAVR)–associated acute kidney injury. Kidney International. 91(6). 1312–1323. 42 indexed citations
16.
Wanchoo, Rimda, Nupur N. Uppal, Valerie S. Barta, et al.. (2017). Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review. American Journal of Nephrology. 45(2). 160–169. 11620 indexed citations breakdown →
17.
Wanchoo, Rimda. (2016). Adverse renal effects of novel molecular oncologic targeted therapies: A review of the FDA Adverse Event Reporting System (FAERS). Journal of Clinical Trials. 6 indexed citations
18.
Wanchoo, Rimda, Kenar D. Jhaveri, Gilbert Deray, & Vincent Launay‐Vacher. (2016). Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network. Clinical Kidney Journal. 9(2). 245–251. 58 indexed citations
19.
Wanchoo, Rimda & Kenar D. Jhaveri. (2015). Nephrology Crosswords: Diabetic nephropathy. Kidney International. 88(3). 647–648. 3 indexed citations
20.
Thakkar, Jyotsana, Rimda Wanchoo, & Kenar D. Jhaveri. (2015). Onconephrology abstracts and publication trends: time to collaborate. Clinical Kidney Journal. 8(5). 629–631. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026